Markets.News

EPIX  ESSA PHARMA INC

+ add to watchlist

$0.20

as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in our approach. we're firmly rooted in creative and open thinking, giving us an energy and approach that makes us a different kind of pharmaceutical company.

Mkt Cap: $9.52M

52 Week High: $1.95

P/E: 0.00

52 Week Low: $0.18

Dividend: $0.00

Shares Outstanding: 47.31M

This news is delayed by 15 minutes, sign up now to get live news & full features.